Outpatient percutaneous liver biopsy: still a good option.
To assess security of "blind" percutaneous liver biopsy as an ambulatory procedure. Defining inclusion criteria, surveillance protocol, data from ultrasonography done 6 h after procedure and complications. We analysed 192 percutaneous liver biopsies done between 2000-2007. There were no major complications and only a small number of minor complications. There were no deaths related to the procedure. It is possible to perform percutaneous liver biopsy as an ambulatory procedure not expecting to find threatening complications.